(Q38206399)

31 August 2017

title

Extracellular adenosine metabolism in immune cells in melanoma (English)

1 reference

31 August 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jochen Utikal

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Viktor Umansky

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Alexandr V Bazhin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

23 April 2014

1 reference

Cancer Immunology, Immunotherapy

31 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

1073-1080

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-014-1553-8

31 May 2020

exact match

0 references

cites work

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Epidemiology of invasive cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Cell transfer immunotherapy for metastatic solid cancer--what clinicians need to know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Therapeutic cancer vaccines: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Immunotherapy for advanced melanoma: fulfilling the promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Molecular Pathways Linking Inflammation and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

New insights into chronic inflammation-induced immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Disarming suppressor cells to improve immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Tumor-associated neutrophils: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Tumor associated regulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Suppression of T-cell responses by tumor metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

21 January 2018

Eicosanoids and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

CD73: a potent suppressor of antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Tumor metabolism as modulator of immune response and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Aspects of the general biology of adenosine A2A signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosine: an endogenous regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosine receptors in regulation of dendritic cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosine promotes alternative macrophage activation via A2A and A2B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Immune cell regulation by autocrine purinergic signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Ecto-5'-nucleotidase: Structure function relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

CD73-deficient mice are resistant to carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Regulatory T cells: mechanisms of differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Autocrine regulation of T-cell activation by ATP release and P2X7 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1553-8

10.1007/S00262-014-1553-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 May 2020

1021296518

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24756420%20AND%20SRC:MED&resulttype=core&format=json